Clinical Trial

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to characterize the epidemiology, clinicopathologic features, and survival outcomes of Chinese patients with PTCL; to develop and validate prognostic models to this population; to compare the real-world effectiveness and safety of alternative therapeutic strategies; to elucidate molecular mechanisms underlying treatment resistance and relapse; to identify actionable targets and predictive biomarkers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-26.
Trial Details
NCT Number NCT07270861
Lead Sponsor Fudan University
Collaborators: The First Affiliated Hospital of Zhengzhou University
Conditions Peripheral T-Cell Lymphoma
Enrollment 3,000 participants
Start Date 2025-11-15
Primary Completion 2030-12-31 (estimated)
Study Completion 2035-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-24